Matos, Marina N <br/><br/>
Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.  [electronic resource] 

 -  PLoS neglected tropical diseases  02 2017 
 - e0005300 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-2735 
<br/><br/><label>Standard No.: </label>10.1371/journal.pntd.0005300  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Animals<br/>Antibodies, Protozoan--immunology<br/>Chagas Disease--immunology<br/>Cyclic AMP--administration & dosage<br/>Female<br/>Humans<br/>Immunization<br/>Mice<br/>Mice, Inbred C3H<br/>Protein Domains<br/>Protozoan Proteins--administration & dosage<br/>Th1 Cells--immunology<br/>Th17 Cells--immunology<br/>Trypanosoma cruzi--chemistry